Distinctive cutaneous features of dermatomyositis in Black adults: A case series
Abstract
DM: dermatomyositis INTRODUCTION Dermatomyositis (DM) is a rare inflammatory myopathy shown to disproportionately affect Black individuals, with estimated incidence 3-fold greater than that in White individuals. As with multiple cutaneous diseases in skin of color, specific manifestations of DM in Black patients remain underreported in educational sources and scientific literature, leading to potential misdiagnoses or diagnostic delays.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.